11 results
8-K
EX-99.1
CHRS
Coherus Biosciences Inc
27 Oct 23
Regulation FD Disclosure
4:19pm
complications include hyperacute graft-versus-host-disease (GVHD), acute GVHD, chronic GVHD, hepatic veno-occlusive disease (VOD) after reduced intensity
10-K
7frzfr h791fl
23 Mar 15
Annual report
12:00am
424B4
w3r5tte5c
6 Nov 14
Prospectus supplement with pricing info
12:00am
DRS
EX-10.9
o4z nllw2p3u6x9c4v
4 Aug 14
Draft registration statement
12:00am
- Prev
- 1
- Next